MAP2K1 and Miyoshi myopathy: In our study, Dox-induced ERK1/2 activation protected MM cells from Dox-induced cell death, as shown when MM lines were pretreated with the MEK1/2 inhibitor, U0126, prior to Dox exposure (Figure 2).